These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 2691129

  • 1. Perindopril: first-line treatment for hypertension.
    Zanchetti A, Desche P.
    Clin Exp Hypertens A; 1989; 11 Suppl 2():555-73. PubMed ID: 2691129
    [Abstract] [Full Text] [Related]

  • 2. [Perindopril: first-line treatment of arterial hypertension].
    Zanchetti A, Desche P.
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():63-72. PubMed ID: 2505715
    [Abstract] [Full Text] [Related]

  • 3. Assessment of antihypertensive efficacy of perindopril: results of double-blind multicenter studies versus reference drugs.
    Thurston H, Desche P.
    J Cardiovasc Pharmacol; 1991 May; 18 Suppl 7():S45-9. PubMed ID: 1725202
    [Abstract] [Full Text] [Related]

  • 4. A double blind comparison of perindopril and atenolol in essential hypertension.
    Thurston H, Mimran A, Zanchetti A, Creytens G, Rorive G, Brown CL, Santoni JP.
    J Hum Hypertens; 1990 Oct; 4(5):547-52. PubMed ID: 2283644
    [Abstract] [Full Text] [Related]

  • 5. Perindopril plus nifedipine versus perindopril plus hydrochlorothiazide in mild to severe hypertension: a double-blind multicentre study. The Multicentre Study Group on Treatment Association with Perindopril.
    Letellier P, Overlack A, Agnes E, Desche P.
    J Hum Hypertens; 1994 Feb; 8(2):145-9. PubMed ID: 8207741
    [Abstract] [Full Text] [Related]

  • 6. Captopril versus perindopril: a double blind study in essential hypertension.
    Lees KR, Reid JL, Scott MG, Hosie J, Herpin D, Santoni JP.
    J Hum Hypertens; 1989 Feb; 3(1):17-22. PubMed ID: 2657055
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study.
    Rosei EA, Rizzoni D, DIMS II (Delapril-Indapamide Multicenter Study II).
    J Hum Hypertens; 2003 Feb; 17(2):139-46. PubMed ID: 12574793
    [Abstract] [Full Text] [Related]

  • 8. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM, Chamontin B, Asmar R, De Leeuw PW, O'Brien E, Duprez D, O'Rourke MF, Rahn KH, Romero R, Battegay E, Hitzenberger G, Safar ME, REASON Project.
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [Abstract] [Full Text] [Related]

  • 9. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 11. An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension.
    Luccioni R, Sever PS, Di Perri T, Redon J, Laurandin I, Brault Y, Chastang C, Guez D.
    J Hypertens; 1995 Dec; 13(12 Pt 2):1847-51. PubMed ID: 8903665
    [Abstract] [Full Text] [Related]

  • 12. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y, Poirier L, Hebert D, Assouline L, Stolt P, Rehel B, Khder Y.
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [Abstract] [Full Text] [Related]

  • 13. [Antihypertensive action, clinical and biological acceptability of perindopril: main results in 23,460 patients with mild to moderate hypertension treated for 6 months in general practice].
    Fressinaud P, Berrut G, Gallois H.
    Ann Cardiol Angeiol (Paris); 1993 Jan; 42(1):51-9. PubMed ID: 8480986
    [Abstract] [Full Text] [Related]

  • 14. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T, Smith TR, Glazer R, Wernsing M, Yen J, Jin J, Schneider H, Pospiech R.
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and acceptability of perindopril in essential hypertension.
    Sukonthasarn A, Ratanaprakarn R, Koanantakul B, Ngam-Ukos P.
    J Med Assoc Thai; 1994 Jun; 77(6):281-7. PubMed ID: 7869013
    [Abstract] [Full Text] [Related]

  • 16. A multicenter, randomized, double-blind, parallel-group trial of the antihypertensive efficacy and tolerability of a combination of once-daily losartan 100 mg/hydrochlorothiazide 12.5 mg compared with losartan 100-mg monotherapy in the treatment of mild to severe essential hypertension.
    Gleim GW, Rubino J, Zhang H, Shahinfar S, Soffer BA, Lyle PA, Littlejohn TW, Feig PU.
    Clin Ther; 2006 Oct; 28(10):1639-48. PubMed ID: 17157119
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ, Leibowitz MT, Weinstein SP, Rowe ED, Mendel CM, Levy B, McMahon FG, Mullican WS, Toth PD, Cutler NR.
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
    Calhoun DA, Glazer RD, Pettyjohn FS, Coenen PD, Zhao Y, Grosso A.
    Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517
    [Abstract] [Full Text] [Related]

  • 19. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL, Glazer R, Weinberger M, Alvarado R, Huang J, Graff A.
    Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin-converting enzyme inhibition as first-line treatment for hypertension.
    Thurston H.
    Clin Exp Pharmacol Physiol Suppl; 1992 Jan; 19():67-71. PubMed ID: 1395119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.